EUVIMEDEUVIMED entdecken
Crossref

Anti-MRSA Cephems: An Update

Dane Springer

Current Medicinal Chemistry -Anti-Infective Agents · 2002

DOI: 10.2174/1568012023354929 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Current Medicinal Chemistry -Anti-Infective Agents, 2002. Verfasst von Dane Springer. Die Arbeit wurde bisher 4-mal zitiert (Crossref).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A review of recent developments in the field of anti-MRSA cephems is presented. The R.W. Johnson / Microcide collaboration seems to be the most advanced effort to date, but many other companies are continuing their efforts to develop a cephalosporin for use against serious Gram-positive infections such as MRSA. A detailed account of the progression of the MRSA cephem program at Bristol-Myers Squibb is provided. This work produced a number of compounds that had excellent biological activity, and were safe in a murine model of acute toxicity. Keywords: anti-mrsa cephem, mrsa cephem

Zitieren

APA

Springer, D. (2002). Anti-MRSA Cephems: An Update. Current Medicinal Chemistry -Anti-Infective Agents. https://doi.org/10.2174/1568012023354929

Vancouver

Springer D. Anti-MRSA Cephems: An Update. Current Medicinal Chemistry -Anti-Infective Agents. 2002. doi:10.2174/1568012023354929

BibTeX
@article{Springer2002,
  author = {Springer, Dane},
  title = {Anti-MRSA Cephems: An Update},
  journal = {Current Medicinal Chemistry -Anti-Infective Agents},
  year = {2002},
  doi = {10.2174/1568012023354929}
}
Kostenlos starten →